Further evaluation and validation of HybridoMed Diff 1000 and its comparison to Basch medium for the cell-free culture of Schistosoma mansoni juvenile worm stages

Shradha Maharjan, Ruth S Kirk, Scott P Lawton, Anthony J Walker

Research output: Contribution to journalShort communication peer-review

Abstract

Schistosomules of the human parasite Schistosoma mansoni are vital for research focusing on the fundamental functional/developmental biology of schistosomes and many anti-schistosomal drug discovery programmes. Through the further evaluation and validation of a recently tested media, HybridoMed Diff 1000 (HM), for the cell-free culture of juvenile schistosomules, we show that while Basch medium was superior to HM for the survival/development of schistosomules, HM represents a viable and attractive alternative for somule culture, particularly to the early liver stage. Adoption of HM for schistosomule culture could facilitate more standardised approaches, which for drug screening should enable improved multi-centre target-hit evaluation.

Original languageEnglish
JournalInternational Journal for Parasitology
Early online date23 Mar 2021
DOIs
Publication statusFirst published - 23 Mar 2021

Keywords

  • Basch
  • HybridoMed
  • Schistosoma mansoni
  • Schistosome culture
  • Schistosomulae

Fingerprint Dive into the research topics of 'Further evaluation and validation of HybridoMed Diff 1000 and its comparison to Basch medium for the cell-free culture of Schistosoma mansoni juvenile worm stages'. Together they form a unique fingerprint.

Cite this